Blood donor study testing safety of donating in health
Part of Infections clinical trials.
This trial studies people who donate blood and checks what happens in your body after donation, focusing on safety and measurements in lab tests. You may be able to join if you are healthy and pass screening labs and health history checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Be in good general health based on screening within 28 days before donating
- Provide written consent (you agree to take part)
- Do not have certain major past or current health problems like diabetes, recent cancer, or recent heart disease
- Pass blood and urine lab checks (including not having hepatitis B/C, HIV, or certain other test results)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood from healthy volunteers to be used in laboratory research. Your blood helps scientists study diseases and test new treatments in the lab.
This is a study that recruits healthy adults to donate a type of blood cell (PBMCs) so researchers can grow T cells for future adoptive cell therapy. It tests a process for collecting and expanding immune cells; participation mainly involves blood donation and health screening.
This study looks at healthy adults who donate platelets to understand how platelets change over time. You must fast before blood draws and avoid certain medicines like aspirin or ibuprofen for a week before each visit.
This trial helps the NCI-Frederick research labs by collecting and sharing samples from healthy, eligible donors. Your samples are used in “in vitro” studies, which means experiments done outside the body (in the lab).
This study collects tissue or blood samples from adults (and some healthy volunteers) to help researchers learn more and plan future studies. If you qualify, your samples may be used to test new ideas related to your health or for exploratory research.
This trial uses a special blood-removal procedure called apheresis to collect either plasma or white blood cells for laboratory research. It may help scientists understand infection or immune-related processes by providing specific blood components for study.
Hear when a new Risk Reduction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.